Dr. Ambady is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Mercy Catholic Medical Cen
Portland, OR 97239Phone+1 215-688-7448
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 2009 - 2012
- Mercy Catholic Medical CenterResidency, Internal Medicine, 2007 - 2009
- OtherClass of 2003
Certifications & Licensure
- OR State Medical License 2014 - 2025
- MD State Medical License 2012 - 2014
- PA State Medical License 2007 - 2012
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response Start of enrollment: 2016 Jul 12
Roles: Contact, Principal Investigator
- Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
Roles: Contact, Principal Investigator
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Roles: Contact
Publications & Presentations
PubMed
- ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu
Journal of Clinical Oncology. 2024-11-08 - Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI.Doonyaporn Wongsawaeng, Daniel Schwartz, Xin Li, Leslie L Muldoon, Jared Stoller
The Neuroradiology Journal. 2024-08-01 - Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes.Jared Stoller, Cymon N Kersch, Leslie L Muldoon, Prakash Ambady, Christina A Harrington
Neuro-Oncology Advances. 2023-11-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: